| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | nuclear receptor activity | 1.72e-09 | 60 | 39 | 6 | GO:0004879 | |
| GeneOntologyMolecularFunction | ligand-activated transcription factor activity | 1.90e-09 | 61 | 39 | 6 | GO:0098531 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | NR2C2 ZNF671 ZNF140 PPARD RARG PPARG NR1D1 ZNF865 ZNF341 NR1D2 ZNF316 ZNF707 | 2.63e-06 | 1244 | 39 | 12 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | NR2C2 ZNF671 ZNF140 PPARD RARG PPARG NR1D1 ZNF865 ZNF341 NR1D2 ZNF316 ZNF707 | 3.28e-06 | 1271 | 39 | 12 | GO:0000987 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | NR2C2 ZNF671 ZNF140 PPARD RARG PPARG NR1D1 ZNF865 ZNF341 NR1D2 ZNF316 ZNF707 | 1.35e-05 | 1459 | 39 | 12 | GO:0000977 |
| GeneOntologyMolecularFunction | pre-mRNA 3'-splice site binding | 7.76e-05 | 7 | 39 | 2 | GO:0030628 | |
| GeneOntologyMolecularFunction | prostaglandin receptor activity | 2.02e-04 | 11 | 39 | 2 | GO:0004955 | |
| GeneOntologyMolecularFunction | prostanoid receptor activity | 2.42e-04 | 12 | 39 | 2 | GO:0004954 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | NR2C2 ZNF140 PPARD RARG PPARG NR1D1 ZNF341 NR1D2 ZNF316 ZNF707 | 2.89e-04 | 1412 | 39 | 10 | GO:0000981 |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 3.77e-04 | 320 | 39 | 5 | GO:0001227 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 4.11e-04 | 326 | 39 | 5 | GO:0001217 | |
| GeneOntologyMolecularFunction | icosanoid receptor activity | 4.38e-04 | 16 | 39 | 2 | GO:0004953 | |
| GeneOntologyMolecularFunction | nuclear retinoid X receptor binding | 9.16e-04 | 23 | 39 | 2 | GO:0046965 | |
| GeneOntologyMolecularFunction | nuclear steroid receptor activity | 1.08e-03 | 25 | 39 | 2 | GO:0003707 | |
| GeneOntologyMolecularFunction | long-chain fatty acid binding | 1.36e-03 | 28 | 39 | 2 | GO:0036041 | |
| GeneOntologyMolecularFunction | zinc ion binding | 1.51e-03 | 891 | 39 | 7 | GO:0008270 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 2.56e-03 | 140 | 39 | 3 | GO:0001221 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 4.46e-03 | 51 | 39 | 2 | GO:0004402 | |
| GeneOntologyMolecularFunction | transcription coactivator binding | 4.99e-03 | 54 | 39 | 2 | GO:0001223 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 5.17e-03 | 55 | 39 | 2 | GO:0061733 | |
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 5.17e-03 | 55 | 39 | 2 | GO:0042974 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 6.13e-03 | 60 | 39 | 2 | GO:0034212 | |
| GeneOntologyMolecularFunction | E-box binding | 6.33e-03 | 61 | 39 | 2 | GO:0070888 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | NR2C2 PRKN CDY2A ZNF140 PPARD RARG PPARG DKK1 NR1D1 PRDM6 ZFP36 NR1D2 CDY1 | 9.34e-07 | 1399 | 39 | 13 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | NR2C2 PRKN CDY2A ZNF140 PPARD RARG PPARG DKK1 NR1D1 PRDM6 ZFP36 NR1D2 CDY1 | 1.05e-06 | 1413 | 39 | 13 | GO:1902679 |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | NR2C2 PRKN ZNF140 PPARD RARG PPARG DKK1 NR1D1 PRDM6 ZFP36 NR1D2 | 2.61e-06 | 1053 | 39 | 11 | GO:0000122 |
| GeneOntologyBiologicalProcess | negative regulation of inflammatory response | 5.39e-06 | 239 | 39 | 6 | GO:0050728 | |
| GeneOntologyBiologicalProcess | regulation of mitochondrial fission | 4.27e-05 | 36 | 39 | 3 | GO:0090140 | |
| GeneOntologyBiologicalProcess | negative regulation of defense response | 4.88e-05 | 353 | 39 | 6 | GO:0031348 | |
| GeneOntologyBiologicalProcess | negative regulation of developmental process | 6.63e-05 | 1220 | 39 | 10 | GO:0051093 | |
| GeneOntologyBiologicalProcess | hormone-mediated signaling pathway | 9.22e-05 | 244 | 39 | 5 | GO:0009755 | |
| GeneOntologyBiologicalProcess | trachea cartilage development | 9.68e-05 | 8 | 39 | 2 | GO:0060534 | |
| GeneOntologyBiologicalProcess | negative regulation of microglial cell activation | 9.68e-05 | 8 | 39 | 2 | GO:1903979 | |
| GeneOntologyBiologicalProcess | negative regulation of mitochondrial fission | 9.68e-05 | 8 | 39 | 2 | GO:0090258 | |
| GeneOntologyBiologicalProcess | intracellular receptor signaling pathway | 1.21e-04 | 416 | 39 | 6 | GO:0030522 | |
| GeneOntologyBiologicalProcess | mitochondrial fission | 1.22e-04 | 51 | 39 | 3 | GO:0000266 | |
| GeneOntologyBiologicalProcess | negative regulation of mitochondrial fusion | 1.24e-04 | 9 | 39 | 2 | GO:0010637 | |
| GeneOntologyBiologicalProcess | mitochondrial fragmentation involved in apoptotic process | 2.27e-04 | 12 | 39 | 2 | GO:0043653 | |
| GeneOntologyBiologicalProcess | negative regulation of cholesterol storage | 2.27e-04 | 12 | 39 | 2 | GO:0010887 | |
| GeneOntologyBiologicalProcess | regulation of fat cell differentiation | 2.80e-04 | 168 | 39 | 4 | GO:0045598 | |
| GeneOntologyBiologicalProcess | negative regulation of response to external stimulus | 3.58e-04 | 509 | 39 | 6 | GO:0032102 | |
| GeneOntologyBiologicalProcess | regulation of inflammatory response | 3.81e-04 | 515 | 39 | 6 | GO:0050727 | |
| GeneOntologyBiologicalProcess | positive regulation of fat cell differentiation | 4.47e-04 | 79 | 39 | 3 | GO:0045600 | |
| GeneOntologyBiologicalProcess | positive regulation of small molecule metabolic process | 4.64e-04 | 192 | 39 | 4 | GO:0062013 | |
| GeneOntologyBiologicalProcess | regulation of mitochondrial fusion | 4.65e-04 | 17 | 39 | 2 | GO:0010635 | |
| GeneOntologyBiologicalProcess | positive regulation of protein secretion | 4.82e-04 | 194 | 39 | 4 | GO:0050714 | |
| GeneOntologyBiologicalProcess | regulation of protein secretion | 4.90e-04 | 350 | 39 | 5 | GO:0050708 | |
| GeneOntologyBiologicalProcess | regulation of hormone secretion | 5.23e-04 | 355 | 39 | 5 | GO:0046883 | |
| GeneOntologyBiologicalProcess | rhythmic process | 5.57e-04 | 360 | 39 | 5 | GO:0048511 | |
| GeneOntologyBiologicalProcess | negative regulation of neuroinflammatory response | 6.48e-04 | 20 | 39 | 2 | GO:0150079 | |
| GeneOntologyBiologicalProcess | regulation of cholesterol storage | 6.48e-04 | 20 | 39 | 2 | GO:0010885 | |
| GeneOntologyBiologicalProcess | negative regulation of macrophage activation | 6.48e-04 | 20 | 39 | 2 | GO:0043031 | |
| GeneOntologyBiologicalProcess | regulation of insulin secretion involved in cellular response to glucose stimulus | 6.99e-04 | 92 | 39 | 3 | GO:0061178 | |
| GeneOntologyBiologicalProcess | regulation of lipid localization | 7.09e-04 | 215 | 39 | 4 | GO:1905952 | |
| GeneOntologyBiologicalProcess | positive regulation of fatty acid oxidation | 7.86e-04 | 22 | 39 | 2 | GO:0046321 | |
| GeneOntologyBiologicalProcess | positive regulation of mitochondrial fission | 7.86e-04 | 22 | 39 | 2 | GO:0090141 | |
| GeneOntologyBiologicalProcess | trachea development | 7.86e-04 | 22 | 39 | 2 | GO:0060438 | |
| GeneOntologyBiologicalProcess | negative regulation of collagen biosynthetic process | 8.60e-04 | 23 | 39 | 2 | GO:0032966 | |
| GeneOntologyBiologicalProcess | regulation of microglial cell activation | 8.60e-04 | 23 | 39 | 2 | GO:1903978 | |
| GeneOntologyBiologicalProcess | insulin secretion involved in cellular response to glucose stimulus | 9.43e-04 | 102 | 39 | 3 | GO:0035773 | |
| GeneOntologyBiologicalProcess | cellular response to tumor necrosis factor | 9.57e-04 | 233 | 39 | 4 | GO:0071356 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid storage | 1.10e-03 | 26 | 39 | 2 | GO:0010888 | |
| GeneOntologyBiologicalProcess | cholesterol storage | 1.10e-03 | 26 | 39 | 2 | GO:0010878 | |
| GeneOntologyBiologicalProcess | hormone secretion | 1.11e-03 | 420 | 39 | 5 | GO:0046879 | |
| GeneOntologyBiologicalProcess | negative regulation of cell differentiation | 1.13e-03 | 875 | 39 | 7 | GO:0045596 | |
| GeneOntologyCellularComponent | mitochondrion-derived vesicle | 9.64e-06 | 3 | 38 | 2 | GO:0099073 | |
| GeneOntologyCellularComponent | U2AF complex | 6.72e-05 | 7 | 38 | 2 | GO:0089701 | |
| MousePheno | thin myocardium | 1.72e-05 | 85 | 26 | 4 | MP:0002652 | |
| MousePheno | abnormal liver triglyceride level | 2.35e-05 | 191 | 26 | 5 | MP:0012778 | |
| MousePheno | decreased liver triglyceride level | 2.56e-05 | 94 | 26 | 4 | MP:0009356 | |
| MousePheno | abnormal subcutaneous adipose tissue amount | 7.58e-05 | 124 | 26 | 4 | MP:0020997 | |
| MousePheno | abnormal white adipose tissue physiology | 7.70e-05 | 45 | 26 | 3 | MP:0005670 | |
| MousePheno | abnormal hypodermis fat layer morphology | 8.07e-05 | 126 | 26 | 4 | MP:0011156 | |
| MousePheno | abnormal adipose tissue physiology | 8.32e-05 | 127 | 26 | 4 | MP:0005666 | |
| MousePheno | decreased abdominal fat pad weight | 1.48e-04 | 10 | 26 | 2 | MP:0009287 | |
| MousePheno | abnormal head development | 2.01e-04 | 62 | 26 | 3 | MP:0012176 | |
| MousePheno | abnormal white adipose tissue morphology | 2.74e-04 | 321 | 26 | 5 | MP:0002970 | |
| MousePheno | abnormal hypodermis morphology | 3.25e-04 | 181 | 26 | 4 | MP:0003705 | |
| MousePheno | abnormal cricoid cartilage morphology | 3.44e-04 | 15 | 26 | 2 | MP:0002258 | |
| MousePheno | abnormal circadian temperature homeostasis | 3.44e-04 | 15 | 26 | 2 | MP:0011020 | |
| MousePheno | abnormal lung vasculature morphology | 3.96e-04 | 78 | 26 | 3 | MP:0004007 | |
| MousePheno | decreased triglyceride level | 3.97e-04 | 348 | 26 | 5 | MP:0005318 | |
| MousePheno | decreased muscle glycogen level | 5.00e-04 | 18 | 26 | 2 | MP:0031615 | |
| MousePheno | decreased skeletal muscle glycogen level | 5.00e-04 | 18 | 26 | 2 | MP:0010399 | |
| MousePheno | decreased brown adipose tissue mass | 5.00e-04 | 18 | 26 | 2 | MP:0014169 | |
| MousePheno | liver vascular congestion | 5.58e-04 | 19 | 26 | 2 | MP:0010019 | |
| MousePheno | reduced fertility | 6.81e-04 | 844 | 26 | 7 | MP:0001921 | |
| MousePheno | absent subcutaneous adipose tissue | 6.84e-04 | 21 | 26 | 2 | MP:0008843 | |
| MousePheno | decreased subcutaneous adipose tissue amount | 7.06e-04 | 95 | 26 | 3 | MP:0008844 | |
| MousePheno | abnormal apical ectodermal ridge morphology | 7.51e-04 | 22 | 26 | 2 | MP:0001676 | |
| MousePheno | abnormal brown adipose tissue mass | 7.51e-04 | 22 | 26 | 2 | MP:0014168 | |
| MousePheno | abnormal cellular glucose uptake | 8.68e-04 | 102 | 26 | 3 | MP:0003925 | |
| MousePheno | increased adipocyte glucose uptake | 8.95e-04 | 24 | 26 | 2 | MP:0030016 | |
| MousePheno | pulmonary vascular congestion | 8.95e-04 | 24 | 26 | 2 | MP:0010018 | |
| MousePheno | decreased cholesterol level | 9.13e-04 | 418 | 26 | 5 | MP:0003983 | |
| MousePheno | decreased systemic arterial blood pressure | 9.18e-04 | 104 | 26 | 3 | MP:0002843 | |
| MousePheno | decreased sterol level | 9.43e-04 | 421 | 26 | 5 | MP:0012225 | |
| MousePheno | abnormal fat cell morphology | 9.71e-04 | 242 | 26 | 4 | MP:0009115 | |
| MousePheno | decreased circulating adiponectin level | 9.72e-04 | 25 | 26 | 2 | MP:0030968 | |
| MousePheno | abnormal interscapular fat pad morphology | 1.05e-03 | 26 | 26 | 2 | MP:0006320 | |
| MousePheno | decreased liver cholesterol level | 1.05e-03 | 26 | 26 | 2 | MP:0010026 | |
| MousePheno | abnormal tracheal cartilage morphology | 1.13e-03 | 27 | 26 | 2 | MP:0003120 | |
| Domain | zf-C4 | 4.14e-10 | 46 | 38 | 6 | PF00105 | |
| Domain | NUCLEAR_REC_DBD_1 | 4.14e-10 | 46 | 38 | 6 | PS00031 | |
| Domain | Znf_hrmn_rcpt | 4.14e-10 | 46 | 38 | 6 | IPR001628 | |
| Domain | Nuclear_hrmn_rcpt | 4.14e-10 | 46 | 38 | 6 | IPR001723 | |
| Domain | ZnF_C4 | 4.14e-10 | 46 | 38 | 6 | SM00399 | |
| Domain | NUCLEAR_REC_DBD_2 | 4.14e-10 | 46 | 38 | 6 | PS51030 | |
| Domain | - | 4.74e-10 | 47 | 38 | 6 | 1.10.565.10 | |
| Domain | HOLI | 5.41e-10 | 48 | 38 | 6 | SM00430 | |
| Domain | Nucl_hrmn_rcpt_lig-bd | 5.41e-10 | 48 | 38 | 6 | IPR000536 | |
| Domain | Hormone_recep | 5.41e-10 | 48 | 38 | 6 | PF00104 | |
| Domain | - | 1.58e-09 | 57 | 38 | 6 | 3.30.50.10 | |
| Domain | Znf_NHR/GATA | 1.76e-09 | 58 | 38 | 6 | IPR013088 | |
| Domain | ZnF_C3H1 | 2.66e-06 | 48 | 38 | 4 | SM00356 | |
| Domain | VitD_rcpt | 2.78e-06 | 14 | 38 | 3 | IPR000324 | |
| Domain | zf-CCCH | 2.89e-06 | 49 | 38 | 4 | PF00642 | |
| Domain | Znf_CCCH | 5.71e-06 | 58 | 38 | 4 | IPR000571 | |
| Domain | ZF_C3H1 | 5.71e-06 | 58 | 38 | 4 | PS50103 | |
| Domain | 1Cnucl_rcpt | 1.21e-05 | 3 | 38 | 2 | IPR003074 | |
| Domain | U2AF_small | 4.02e-05 | 5 | 38 | 2 | IPR009145 | |
| Domain | Chromo_dom_subgr | 1.80e-04 | 10 | 38 | 2 | IPR017984 | |
| Domain | Growth_fac_rcpt_ | 2.77e-04 | 156 | 38 | 4 | IPR009030 | |
| Domain | - | 3.84e-04 | 679 | 38 | 7 | 3.30.160.60 | |
| Domain | zf-C2H2 | 4.34e-04 | 693 | 38 | 7 | PF00096 | |
| Domain | Znf_C2H2/integrase_DNA-bd | 4.38e-04 | 694 | 38 | 7 | IPR013087 | |
| Domain | Crotonase_core_superfam | 5.38e-04 | 17 | 38 | 2 | IPR001753 | |
| Domain | ECH_1 | 5.38e-04 | 17 | 38 | 2 | PF00378 | |
| Domain | KRAB | 7.51e-04 | 358 | 38 | 5 | PS50805 | |
| Domain | KRAB | 7.51e-04 | 358 | 38 | 5 | PF01352 | |
| Domain | ZINC_FINGER_C2H2_2 | 8.45e-04 | 775 | 38 | 7 | PS50157 | |
| Domain | ZINC_FINGER_C2H2_1 | 8.57e-04 | 777 | 38 | 7 | PS00028 | |
| Domain | KRAB | 8.60e-04 | 369 | 38 | 5 | SM00349 | |
| Domain | KRAB | 8.71e-04 | 370 | 38 | 5 | IPR001909 | |
| Domain | Znf_C2H2-like | 9.88e-04 | 796 | 38 | 7 | IPR015880 | |
| Domain | Znf_C2H2 | 1.05e-03 | 805 | 38 | 7 | IPR007087 | |
| Domain | ZnF_C2H2 | 1.08e-03 | 808 | 38 | 7 | SM00355 | |
| Domain | Chromo | 1.27e-03 | 26 | 38 | 2 | PF00385 | |
| Domain | CHROMO_2 | 1.47e-03 | 28 | 38 | 2 | PS50013 | |
| Domain | CHROMO_1 | 1.47e-03 | 28 | 38 | 2 | PS00598 | |
| Domain | Chromodomain-like | 1.92e-03 | 32 | 38 | 2 | IPR016197 | |
| Domain | CHROMO | 2.05e-03 | 33 | 38 | 2 | SM00298 | |
| Domain | Chromo/shadow_dom | 2.05e-03 | 33 | 38 | 2 | IPR000953 | |
| Domain | Laminin_EGF | 2.30e-03 | 35 | 38 | 2 | PF00053 | |
| Domain | EGF_Lam | 2.30e-03 | 35 | 38 | 2 | SM00180 | |
| Domain | Laminin_EGF | 2.71e-03 | 38 | 38 | 2 | IPR002049 | |
| Domain | - | 2.99e-03 | 40 | 38 | 2 | 4.10.1000.10 | |
| Domain | zf-C2H2_6 | 3.69e-03 | 314 | 38 | 4 | PF13912 | |
| Domain | Galactose-bd-like | 1.57e-02 | 94 | 38 | 2 | IPR008979 | |
| Pathway | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | 1.17e-09 | 53 | 30 | 6 | M8276 | |
| Pathway | WP_NUCLEAR_RECEPTORS | 1.47e-08 | 38 | 30 | 5 | MM15865 | |
| Pathway | WP_NUCLEAR_RECEPTORS | 1.47e-08 | 38 | 30 | 5 | M39657 | |
| Pathway | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | 4.94e-08 | 48 | 30 | 5 | MM14987 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | U2AF1L4 ZNF747 U2AF1 NR2C2 ZNF671 ZNF140 PPARD RARG PPARG NR1D1 NR1D2 ZNF707 | 1.26e-05 | 1387 | 30 | 12 | M734 |
| Pathway | PID_RXR_VDR_PATHWAY | 2.19e-05 | 26 | 30 | 3 | M162 | |
| Pathway | WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY | 3.40e-05 | 30 | 30 | 3 | MM15866 | |
| Pathway | BIOCARTA_NUCLEARRS_PATHWAY | 4.55e-05 | 33 | 30 | 3 | MM1448 | |
| Pathway | BIOCARTA_NUCLEARRS_PATHWAY | 4.98e-05 | 34 | 30 | 3 | M16393 | |
| Pathway | WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY | 5.44e-05 | 35 | 30 | 3 | M39488 | |
| Pathway | WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA | 1.38e-03 | 26 | 30 | 2 | M39407 | |
| Pubmed | Automated yeast two-hybrid screening for nuclear receptor-interacting proteins. | 8.21e-09 | 133 | 39 | 6 | 15604093 | |
| Pubmed | 2.60e-08 | 6 | 39 | 3 | 16751185 | ||
| Pubmed | Interaction of nuclear receptor zinc finger DNA binding domains with histone deacetylase. | 2.14e-07 | 11 | 39 | 3 | 12943985 | |
| Pubmed | 7.23e-07 | 16 | 39 | 3 | 25577283 | ||
| Pubmed | Mechanisms of vascular dysfunction in mice with endothelium-specific deletion of the PPAR-δ gene. | 1.23e-06 | 2 | 39 | 2 | 24486511 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 23374874 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 14677574 | ||
| Pubmed | Mitochondrial division ensures the survival of postmitotic neurons by suppressing oxidative damage. | 1.23e-06 | 2 | 39 | 2 | 22564413 | |
| Pubmed | Pleiotropic effects of peroxisome proliferator-activated receptor γ and δ in vascular diseases. | 1.23e-06 | 2 | 39 | 2 | 24107399 | |
| Pubmed | The Impact of PPARD and PPARG Polymorphisms on Glioma Risk and Prognosis. | 1.23e-06 | 2 | 39 | 2 | 32198386 | |
| Pubmed | Circadian clock protein Rev-erbα regulates neuroinflammation. | 1.23e-06 | 2 | 39 | 2 | 30792350 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 33075048 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 12059785 | ||
| Pubmed | Parkin Protects against Oxygen-Glucose Deprivation/Reperfusion Insult by Promoting Drp1 Degradation. | 1.23e-06 | 2 | 39 | 2 | 27597885 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 32798635 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 23545576 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 22021335 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 20645257 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 38070814 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 12821652 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 21192919 | ||
| Pubmed | Reverse Erythroblastosis Virus α Antagonism Promotes Homocysteine Catabolism and Ammonia Clearance. | 1.23e-06 | 2 | 39 | 2 | 31016736 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 38142970 | ||
| Pubmed | Bifunctional role of Rev-erbalpha in adipocyte differentiation. | 1.23e-06 | 2 | 39 | 2 | 18227153 | |
| Pubmed | Deregulation of tumor angiogenesis and blockade of tumor growth in PPARbeta-deficient mice. | 1.23e-06 | 2 | 39 | 2 | 17641685 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 25556996 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 19283612 | ||
| Pubmed | Cinnamaldehyde Contributes to Insulin Sensitivity by Activating PPARδ, PPARγ, and RXR. | 1.23e-06 | 2 | 39 | 2 | 26227398 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 25715097 | ||
| Pubmed | Identification of heme as the ligand for the orphan nuclear receptors REV-ERBalpha and REV-ERBbeta. | 1.23e-06 | 2 | 39 | 2 | 18037887 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 18288282 | ||
| Pubmed | SR9009 has REV-ERB-independent effects on cell proliferation and metabolism. | 1.23e-06 | 2 | 39 | 2 | 31127047 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 32439175 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 17713572 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 18379566 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 29723273 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 21843327 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 32664384 | ||
| Pubmed | PPARβ/δ activation protects against hepatic ischaemia-reperfusion injury. | 1.23e-06 | 2 | 39 | 2 | 37833850 | |
| Pubmed | Activation of PPARγ and δ by dietary punicic acid ameliorates intestinal inflammation in mice. | 1.23e-06 | 2 | 39 | 2 | 21736821 | |
| Pubmed | Rev-erbα and Rev-erbβ coordinately protect the circadian clock and normal metabolic function. | 1.23e-06 | 2 | 39 | 2 | 22474260 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 26028469 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 21070867 | ||
| Pubmed | SR9009 improves heart function after pressure overload independent of cardiac REV-ERB. | 1.23e-06 | 2 | 39 | 2 | 35911512 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 20840271 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 22544925 | ||
| Pubmed | Parkin-independent mitophagy requires Drp1 and maintains the integrity of mammalian heart and brain. | 1.23e-06 | 2 | 39 | 2 | 25349190 | |
| Pubmed | Hormone-sensitive lipase modulates adipose metabolism through PPARγ. | 1.23e-06 | 2 | 39 | 2 | 20950707 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 33021965 | ||
| Pubmed | Impact of circadian nuclear receptor REV-ERBα on midbrain dopamine production and mood regulation. | 1.23e-06 | 2 | 39 | 2 | 24813609 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 19395102 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 12740443 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 27267045 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 20348464 | ||
| Pubmed | PPARbeta/delta potentiates PPARgamma-stimulated adipocyte differentiation. | 1.23e-06 | 2 | 39 | 2 | 15247146 | |
| Pubmed | The hepatocyte clock and feeding control chronophysiology of multiple liver cell types. | 1.23e-06 | 2 | 39 | 2 | 32732282 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 38704134 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 32116123 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 38255844 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 20427759 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 23273766 | ||
| Pubmed | Phosphorylation of N-terminal regions of REV-ERBs regulates their intracellular localization. | 1.23e-06 | 2 | 39 | 2 | 29508494 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 27181353 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 31800167 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 24205877 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 20221637 | ||
| Pubmed | Potentiation of colon cancer susceptibility in mice by colonic epithelial PPAR-δ/β overexpression. | 1.23e-06 | 2 | 39 | 2 | 24681603 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 19389799 | ||
| Pubmed | A Y2H-seq approach defines the human protein methyltransferase interactome. | 2.15e-06 | 342 | 39 | 6 | 23455924 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 27512842 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 9113987 | ||
| Pubmed | Nuclear hormone receptor coregulators in action: diversity for shared tasks. | 3.67e-06 | 3 | 39 | 2 | 10707952 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 29346772 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 20075336 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 25758678 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 26332656 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 32143325 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 15917308 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 26098621 | ||
| Pubmed | Roles of PPARs on regulating myocardial energy and lipid homeostasis. | 3.67e-06 | 3 | 39 | 2 | 17356846 | |
| Pubmed | REV-ERBα and REV-ERBβ function as key factors regulating Mammalian Circadian Output. | 3.67e-06 | 3 | 39 | 2 | 31308426 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 27860527 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 20621019 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 23262340 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 28292576 | ||
| Pubmed | Peroxisome proliferator-activated receptors in squamous cell carcinoma and its precursors. | 3.67e-06 | 3 | 39 | 2 | 15811118 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 27179975 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 22944052 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 21292769 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 15128052 | ||
| Pubmed | Ligand modulated antagonism of PPARgamma by genomic and non-genomic actions of PPARdelta. | 3.67e-06 | 3 | 39 | 2 | 19756148 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 21765467 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 29762540 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 11979403 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 18657264 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 18323470 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 23811234 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 8948627 | ||
| Pubmed | Effects of PPARs/20-HETE on the renal impairment under diabetic conditions. | 3.67e-06 | 3 | 39 | 2 | 31163124 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 8240342 | ||
| Interaction | NOTCH2 interactions | 1.23e-06 | 423 | 39 | 8 | int:NOTCH2 | |
| Interaction | HDAC3 interactions | 2.05e-06 | 313 | 39 | 7 | int:HDAC3 | |
| Interaction | NCOR1 interactions | 5.44e-06 | 363 | 39 | 7 | int:NCOR1 | |
| Interaction | RXRB interactions | 7.92e-06 | 66 | 39 | 4 | int:RXRB | |
| Interaction | LTBP2 interactions | 2.17e-05 | 85 | 39 | 4 | int:LTBP2 | |
| Interaction | PRMT2 interactions | 2.84e-05 | 91 | 39 | 4 | int:PRMT2 | |
| Interaction | CFAP20 interactions | 2.84e-05 | 91 | 39 | 4 | int:CFAP20 | |
| Interaction | JMJD6 interactions | 4.51e-05 | 205 | 39 | 5 | int:JMJD6 | |
| Interaction | ZNF747 interactions | 6.30e-05 | 40 | 39 | 3 | int:ZNF747 | |
| Interaction | PROX1 interactions | 6.79e-05 | 41 | 39 | 3 | int:PROX1 | |
| Interaction | RXRG interactions | 1.02e-04 | 47 | 39 | 3 | int:RXRG | |
| Interaction | SAFB interactions | 1.03e-04 | 244 | 39 | 5 | int:SAFB | |
| Interaction | LLGL2 interactions | 1.25e-04 | 133 | 39 | 4 | int:LLGL2 | |
| Cytoband | 3p25 | 3.82e-07 | 17 | 39 | 3 | 3p25 | |
| Cytoband | 20q13.3 | 1.32e-04 | 20 | 39 | 2 | 20q13.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3p25 | 3.16e-04 | 155 | 39 | 3 | chr3p25 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | 3.24e-03 | 1192 | 39 | 5 | chr19q13 | |
| Cytoband | 21q22.3 | 5.34e-03 | 128 | 39 | 2 | 21q22.3 | |
| GeneFamily | Nuclear hormone receptors | 2.48e-10 | 49 | 32 | 6 | 71 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 2.68e-05 | 718 | 32 | 8 | 28 | |
| ToppCell | (09)_Ionocytes|World / shred by cell type and Timepoint | 5.88e-06 | 135 | 39 | 4 | 237b9b646513ca6e4b754c0da95d24015b3661f7 | |
| Drug | n-heptyl-beta-d-glucopyranoside | 2.86e-06 | 2 | 39 | 2 | CID000113557 | |
| Drug | indeglitazar | 8.57e-06 | 3 | 39 | 2 | CID011395145 | |
| Drug | 3-{5-methoxy-1-[(4-methoxyphenyl)sulfonyl]-1H-indol-3-yl}propanoic acid | 8.57e-06 | 3 | 39 | 2 | DB07724 | |
| Drug | Bezafibrate | 8.57e-06 | 3 | 39 | 2 | DB01393 | |
| Drug | 2-methyl-c-5-(4-(5-methyl-2-(4-methylphenyl)-4-oxazolyl)butyl)-1,3-dioxane-r-2-carboxylic acid | 8.57e-06 | 3 | 39 | 2 | ctd:C487401 | |
| Drug | disodium (R,R)-5-(2-((2-(3-chlorophenyl)-2-hydroxyethyl)-amino)propyl)-1,3-benzodioxole-2,3-dicarboxylate | 1.18e-05 | 26 | 39 | 3 | ctd:C076126 | |
| Drug | AC1MHGE4 | 1.71e-05 | 4 | 39 | 2 | CID003025998 | |
| Drug | Ro 41-5253 | 1.83e-05 | 30 | 39 | 3 | ctd:C084904 | |
| Drug | cyclopentanone | 2.02e-05 | 31 | 39 | 3 | CID000008452 | |
| Drug | estradiol, USP; Up 200; 0.1uM; MCF7; HG-U133A | 2.09e-05 | 197 | 39 | 5 | 365_UP | |
| Drug | Furaltadone hydrochloride [3759-92-0]; Down 200; 11uM; PC3; HT_HG-U133A | 2.14e-05 | 198 | 39 | 5 | 3756_DN | |
| Drug | octadecenedioic acid | 2.85e-05 | 5 | 39 | 2 | CID006440435 | |
| Drug | Dioctyl Sulfosuccinic Acid | 2.85e-05 | 5 | 39 | 2 | ctd:D004143 | |
| Drug | 2-ethylhexanoic acid | 2.85e-05 | 5 | 39 | 2 | ctd:C040668 | |
| Drug | Heptanoic Acids | 2.85e-05 | 5 | 39 | 2 | ctd:D006538 | |
| Drug | AC1L9JWY | 2.85e-05 | 5 | 39 | 2 | CID000446639 | |
| Drug | Sudan II | 4.14e-05 | 113 | 39 | 4 | CID005354447 | |
| Drug | norathyriol | 4.27e-05 | 6 | 39 | 2 | ctd:C069053 | |
| Drug | 8-hydroxyeicosatetraenoic acid | 4.27e-05 | 6 | 39 | 2 | ctd:C047628 | |
| Drug | ethyl(E,E,E)-7-(2-n-propoxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-naphthalen-3-yl)-6-fluorp-3-methylocta-2,4,6-trienoate | 4.27e-05 | 6 | 39 | 2 | ctd:C504648 | |
| Drug | 4-chloro-N-(2-((5-trifluoromethyl-2-pyridyl)sulfonyl)ethyl)benzamide | 4.27e-05 | 6 | 39 | 2 | ctd:C547957 | |
| Drug | GW2433 | 4.27e-05 | 6 | 39 | 2 | CID000001517 | |
| Drug | cilnidipine | 5.97e-05 | 7 | 39 | 2 | ctd:C065927 | |
| Drug | LY 518674 | 5.97e-05 | 7 | 39 | 2 | ctd:C479889 | |
| Drug | lacidipine | 5.97e-05 | 7 | 39 | 2 | ctd:C060285 | |
| Drug | Carotenoids | 5.97e-05 | 7 | 39 | 2 | ctd:D002338 | |
| Drug | Betamethasone-d5 | 6.37e-05 | 1340 | 39 | 10 | CID000003003 | |
| Drug | benzoxazinone analogue | 7.95e-05 | 8 | 39 | 2 | CID000468715 | |
| Drug | PPAPs | 7.95e-05 | 8 | 39 | 2 | CID009576869 | |
| Drug | SCH 351591 | 7.95e-05 | 8 | 39 | 2 | ctd:C459379 | |
| Drug | perfluorooctanoic acid | 8.11e-05 | 49 | 39 | 3 | CID000009554 | |
| Drug | 9,11-octadecadienoic acid | 1.01e-04 | 142 | 39 | 4 | CID000074607 | |
| Drug | chiglitazar | 1.02e-04 | 9 | 39 | 2 | ctd:C515629 | |
| Drug | monoisononylphthalate | 1.02e-04 | 9 | 39 | 2 | ctd:C471400 | |
| Drug | trifloxystrobin | 1.02e-04 | 9 | 39 | 2 | ctd:C467051 | |
| Drug | Fatty Acids | 1.15e-04 | 55 | 39 | 3 | ctd:D005227 | |
| Drug | oleoyl-estrone | 1.15e-04 | 55 | 39 | 3 | ctd:C108709 | |
| Drug | ezetimibe | 1.15e-04 | 147 | 39 | 4 | CID000150311 | |
| Drug | Fatty Acids, Nonesterified | 1.21e-04 | 56 | 39 | 3 | ctd:D005230 | |
| Drug | Wy-14,643 | 1.23e-04 | 286 | 39 | 5 | CID000005694 | |
| Drug | AC1NUP8U | 1.28e-04 | 10 | 39 | 2 | CID005487216 | |
| Drug | 15(S)-HETrE | 1.28e-04 | 10 | 39 | 2 | CID000001437 | |
| Drug | mono-benzyl phthalate | 1.28e-04 | 10 | 39 | 2 | ctd:C103325 | |
| Drug | Icosapent | 1.28e-04 | 10 | 39 | 2 | DB00159 | |
| Drug | 1,4-dihydropyridine | 1.28e-04 | 10 | 39 | 2 | ctd:C038806 | |
| Drug | mangrove | 1.34e-04 | 468 | 39 | 6 | CID000000965 | |
| Drug | Lanatoside C [17575-22-3]; Up 200; 4uM; PC3; HT_HG-U133A | 1.56e-04 | 159 | 39 | 4 | 4328_UP | |
| Drug | Anti-Inflammatory Agents, Non-Steroidal | 1.56e-04 | 11 | 39 | 2 | ctd:D000894 | |
| Drug | resveratrol-4'-O-glucuronide | 1.56e-04 | 11 | 39 | 2 | ctd:C499731 | |
| Drug | glucosamine 6-phosphate | 1.56e-04 | 11 | 39 | 2 | ctd:C001293 | |
| Drug | UVI 3003 | 1.56e-04 | 11 | 39 | 2 | ctd:C525131 | |
| Drug | Musk T | 1.56e-04 | 11 | 39 | 2 | CID000061014 | |
| Drug | 17-[2-hydroxy-6-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-3-[(2S,3R,4S,5S)-5-hydroxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-[(2S,3R,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-4,4,8,14-tetramethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-10-carbaldehyde | 1.56e-04 | 11 | 39 | 2 | CID011968562 | |
| Drug | GW501516 | 1.87e-04 | 12 | 39 | 2 | CID009803963 | |
| Drug | dioxinodehydroeckol | 1.87e-04 | 12 | 39 | 2 | ctd:C550453 | |
| Drug | Ertiprotafib | 1.87e-04 | 12 | 39 | 2 | CID000157049 | |
| Drug | tetradecylselenoacetic acid | 1.87e-04 | 12 | 39 | 2 | ctd:C410666 | |
| Drug | NSC46155 | 1.87e-04 | 12 | 39 | 2 | CID000457869 | |
| Drug | ciglitazone | 1.97e-04 | 169 | 39 | 4 | CID000002750 | |
| Drug | 2-bromopalmitate | 1.97e-04 | 66 | 39 | 3 | CID000082145 | |
| Drug | 2dxs | 2.20e-04 | 13 | 39 | 2 | CID011987832 | |
| Drug | GW2331 | 2.20e-04 | 13 | 39 | 2 | CID000657048 | |
| Drug | 2-bromopalmitate | 2.20e-04 | 13 | 39 | 2 | ctd:C022776 | |
| Drug | Cephaeline dihydrochloride heptahydrate [6487-30-5]; Up 200; 6uM; PC3; HT_HG-U133A | 2.25e-04 | 175 | 39 | 4 | 4651_UP | |
| Drug | dopamine quinone | 2.25e-04 | 69 | 39 | 3 | CID000162602 | |
| Drug | N-(3-oxododecanoyl)-L-homoserine lactone | 2.57e-04 | 14 | 39 | 2 | CID000127864 | |
| Drug | Idarubicin | 2.96e-04 | 15 | 39 | 2 | ctd:D015255 | |
| Drug | Griseofulvin | 3.11e-04 | 77 | 39 | 3 | ctd:D006118 | |
| Drug | AC1L1BEH | 3.23e-04 | 78 | 39 | 3 | CID000001404 | |
| Drug | Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 3.33e-04 | 194 | 39 | 4 | 3606_DN | |
| Drug | 4-(4-(3-(4-trifluoromethoxy-phenyl)ureido)cyclohexyloxy)benzoic acid | 3.38e-04 | 16 | 39 | 2 | ctd:C572961 | |
| Drug | BM 17.0744 | 3.38e-04 | 16 | 39 | 2 | CID009929731 | |
| Drug | anti-oxLDL | 3.38e-04 | 16 | 39 | 2 | CID003083542 | |
| Drug | Benzamides | 3.38e-04 | 16 | 39 | 2 | ctd:D001549 | |
| Drug | 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid | 3.38e-04 | 16 | 39 | 2 | ctd:D019377 | |
| Drug | Methyldopate hydrochloride [2508-79-4]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 3.53e-04 | 197 | 39 | 4 | 7360_UP | |
| Drug | Bromopride [4093-35-0]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 3.60e-04 | 198 | 39 | 4 | 6037_DN | |
| Drug | T0901317 | 3.61e-04 | 81 | 39 | 3 | CID000447912 | |
| Drug | Dihydroergotamine tartrate [5989-77-5]; Down 200; 3uM; MCF7; HT_HG-U133A | 3.67e-04 | 199 | 39 | 4 | 6840_DN | |
| Drug | Tranylcypromine hydrochloride [1986-47-6]; Down 200; 23.6uM; MCF7; HT_HG-U133A | 3.74e-04 | 200 | 39 | 4 | 5996_DN | |
| Drug | AC1L1F9Q | 3.81e-04 | 201 | 39 | 4 | CID000003144 | |
| Drug | GW0072 | 3.83e-04 | 17 | 39 | 2 | CID000449532 | |
| Drug | AC1NP8CI | 3.83e-04 | 17 | 39 | 2 | CID005153863 | |
| Drug | sulfenamido-sulfonamides | 3.83e-04 | 17 | 39 | 2 | CID000065823 | |
| Drug | JTT-501 | 3.83e-04 | 17 | 39 | 2 | CID000154000 | |
| Drug | 22-hydroxycholesterol | 4.02e-04 | 84 | 39 | 3 | CID000107724 | |
| Drug | diisodecyl phthalate | 4.16e-04 | 85 | 39 | 3 | ctd:C042080 | |
| Drug | dodecylthioacetic acid | 4.30e-04 | 18 | 39 | 2 | CID000083701 | |
| Drug | HX600 | 4.30e-04 | 18 | 39 | 2 | CID000128016 | |
| Drug | perfluorobutane | 4.30e-04 | 18 | 39 | 2 | ctd:C108042 | |
| Drug | b-Mo | 4.30e-04 | 18 | 39 | 2 | CID011427297 | |
| Drug | AS-6 | 4.30e-04 | 18 | 39 | 2 | CID006438999 | |
| Drug | AC1L419E | 4.80e-04 | 19 | 39 | 2 | CID000099951 | |
| Drug | AC1L1AH5 | 4.91e-04 | 215 | 39 | 4 | CID000000986 | |
| Drug | tocopherol | 5.09e-04 | 91 | 39 | 3 | CID000014986 | |
| Drug | KRP-297 | 5.33e-04 | 20 | 39 | 2 | CID000151183 | |
| Drug | 4-PBA | 5.73e-04 | 224 | 39 | 4 | CID000004775 | |
| Drug | 2-ethylhexanoic acid | 5.88e-04 | 21 | 39 | 2 | CID000008697 | |
| Drug | Cu-O | 5.88e-04 | 21 | 39 | 2 | CID000014829 | |
| Drug | Olive Oil | 5.95e-04 | 96 | 39 | 3 | ctd:D000069463 | |
| Disease | Familial partial lipodystrophy | 1.53e-05 | 5 | 37 | 2 | cv:C0271694 | |
| Disease | Familial Partial Lipodystrophy, Type 3 | 3.20e-05 | 7 | 37 | 2 | C1720861 | |
| Disease | Familial Partial Lipodystrophy, Type 2 | 3.20e-05 | 7 | 37 | 2 | C1720860 | |
| Disease | Familial Partial Lipodystrophy, Type 1 | 3.20e-05 | 7 | 37 | 2 | C1720859 | |
| Disease | arteriosclerosis (implicated_via_orthology) | 3.20e-05 | 7 | 37 | 2 | DOID:2349 (implicated_via_orthology) | |
| Disease | Familial partial lipodystrophy | 4.26e-05 | 8 | 37 | 2 | C0271694 | |
| Disease | Spermatogenic Failure, Nonobstructive, Y-Linked | 1.82e-04 | 16 | 37 | 2 | C1839071 | |
| Disease | SPERMATOGENIC FAILURE, Y-LINKED, 2 | 1.82e-04 | 16 | 37 | 2 | 415000 | |
| Disease | Spermatogenic failure, Y-linked, 2 | 1.82e-04 | 16 | 37 | 2 | cv:C1839071 | |
| Disease | Pseudopelade | 2.58e-04 | 19 | 37 | 2 | C0086873 | |
| Disease | fear of minor pain measurement | 6.95e-04 | 31 | 37 | 2 | EFO_0008340 | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 8.31e-04 | 147 | 37 | 3 | DOID:9352 (biomarker_via_orthology) | |
| Disease | Endometrioma | 1.08e-03 | 161 | 37 | 3 | C0269102 | |
| Disease | Endometriosis | 1.08e-03 | 161 | 37 | 3 | C0014175 | |
| Disease | atrial fibrillation | 1.17e-03 | 371 | 37 | 4 | EFO_0000275 | |
| Disease | Malignant neoplasm of breast | 2.03e-03 | 1074 | 37 | 6 | C0006142 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FCCGLDFGYFVKHLR | 341 | Q9Y6F8 | |
| VFCCGLDFGYFVRHL | 341 | Q9Y6F7 | |
| CGGARICYIFHETFG | 361 | O00429 | |
| LGFCFEVHRAVKCGY | 31 | Q96GX2 | |
| CFHLVGEKRTFFGCR | 36 | Q8TAX9 | |
| TGHQDKVRCFFCYGG | 116 | Q96CA5 | |
| AGECRFGDACVYLHG | 176 | Q9H000 | |
| GRHYGAVSCEGCKGF | 126 | P49116 | |
| HYGVSSCEGCKGFFR | 101 | P13631 | |
| DRPFKCGYCGRAFAG | 526 | Q9NQX0 | |
| GFHYGVHACEGCKGF | 141 | P20393 | |
| FGVHRCADGGLYCKE | 76 | Q04446 | |
| YCKGDCPRAVGHRYG | 381 | O60383 | |
| KGSHGLEIFQRCYCG | 226 | O94907 | |
| HKGCFYGRCLGFQFT | 461 | Q05469 | |
| CHACRPGFYKAFAGN | 276 | Q9UF33 | |
| CNGYFVFGRHVCALE | 96 | P03999 | |
| GVHACEGCKGFFRRS | 116 | Q14995 | |
| DLYIDFGGKFHCVCR | 111 | Q9Y2Q9 | |
| GFAFCRECKEAYHEG | 361 | O60260 | |
| YGVHACEGCKGFFRR | 86 | Q03181 | |
| AGKRCDRCAHGFYAY | 976 | P25391 | |
| YGVHACEGCKGFFRR | 151 | P37231 | |
| DFRCCAVLGRGHFGK | 656 | Q16513 | |
| TKCKVGFYLHRGRCF | 111 | Q6UXX9 | |
| GLGIHFDCSGKYRCR | 66 | P57727 | |
| KRFYECGHCGKGFRH | 341 | Q96C28 | |
| GQVRRVKGFHSCCYD | 506 | Q7RTX0 | |
| FRCAGCAKGFSRHKY | 711 | Q9BYN7 | |
| SGFLMGQRYHRCGEC | 276 | Q8TAW3 | |
| GQRYHRCGECGKAFT | 281 | Q8TAW3 | |
| GERAYRCEHCGKGFF | 956 | P0CJ78 | |
| GECRCRHGYFGANCD | 96 | Q96GP6 | |
| RADQRHGCYVCGKSF | 176 | Q9BV97 | |
| GRCRYGAKCQFAHGL | 116 | P26651 | |
| YFKIGACRHGDRCSR | 21 | Q01081 | |
| YFKIGVCRHGDRCSR | 21 | Q8WU68 | |
| CAFCGAGFGRRSYLV | 431 | A6NFI3 | |
| YGCHECGKTFGRRFS | 161 | P52738 | |
| RACRCRTGFFAHAGF | 111 | O95407 |